Maximilian is a Research Fellow within CPEC and ÐÓ°ÉÂÛ̳ Health and part-time PhD student in the Department of Health Policy at ÐÓ°ÉÂÛ̳. He holds an MSc in Health Policy, Planning and Financing from ÐÓ°ÉÂÛ̳ and the London School of Hygiene and Tropical Medicine. Prior to moving to London, he completed his undergraduate studies in Economics at the Vienna University of Economics and Business and worked as a research assistant at the Institute for Advanced Studies in Vienna, Austria.
Maximilian’s research interests include evidence synthesis, comparative effectiveness research, decision-making at the patient and population levels, pharmaceutical regulation and economic evaluation across a range of therapeutic areas, including dementia, cancer, and heart disease. He currently works on a large-scale systematic review and meta-analysis of dementia interventions in low- and middle-income countries as part of the international .
In his PhD, Maximilian focuses on evidence requirements for drug marketing authorisation, critically reviewing recent developments in medicines regulation aimed at accelerating market approval for new medicines.